Adhesion barriers are medical implants used to prevent the formation of scarring or adhesion between tissues and organs following surgical procedures. Adhesion is formed between tissues and organs as the healing procedure begins after surgery. Adhesion could lead to severe medical complications such as post-surgical morbidity, chronic pelvic pain, bowel obstruction, and chronic abdominal pain. It is most commonly and frequently caused after abdominal and gynecological surgery. Around 93% patients who undergo laparotomy surgical procedures develop adhesion. Several studies have indicated that, between 50% and 90% women undergoing gynecological surgery tend to develop post-operative intra-abdominal adhesion. In order to effectively deal with post-operative adhesion, several adhesion barriers have been developed during the past few years. The most commonly used adhesion barrier products include ADEPT, Gynecare Interceed, and Seprafilm. These are available in different formulations such as liquid, gel, and film.
In terms of revenue, the global adhesion barriers market is projected to expand at a CAGR of ~ 7% during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the adhesion barriers market report.
Partnerships & Collaborations and New Product Developments & Launches in International Market – Key Trends among Leading Players
The report provides profiles of the leading players operating in the global adhesion barriers market. Baxter International, Inc., Ethicon US, LLC, FzioMed, Inc., Sanofi, and Integra LifeSciences Corporation are the prominent players operating in the adhesion barriers market. These players have adopted strategies such as partnerships & collaborations and new product developments & launches to increase their market presence. In October 2018, FzioMed announced the launch of a new adhesion barrier product – Oxiplex. It is an adhesion barrier gel that is used during an intrauterine surgery.
Request Sample of the Report:
Hospitals – Prominent End User
Based on end user, the hospitals segment is estimated to constitute a dominant share of the global adhesion barriers market from 2019 to 2027.A large share of the segment can be ascribed to the high number of abdominal surgeries that are performed in hospital settings. The ambulatory surgical centers segment is also projected to be a key segment of the adhesion barriers market during the forecast period. The segment is likely to expand at a high CAGR from 2019 to 2027 in the adhesion barriers market.
4DryField PH to be Highly Attractive
The report offers detailed segmentation of the global adhesion barriers market based on product, application, formulation, and end user. In terms of product, the Seprafilm segment is poised to account for a leading share of the global market during the forecast period, as it has been clinically proven to be effective at reducing post-operative adhesion. The 4DryField PH segment is anticipated to expand at a high CAGR during the forecast period. 4DryField PH is an adhesion barrier gel. 4DryField PH is the only product approved by the European Medicines Agency as a hemostatic agent as well as an adhesion barrier agent. It is commonly used for the prevention of adhesion in abdominal surgical procedures. The segment is estimated to witness strong growth in the adhesion barriers market due to an increase in the usage of the product for different types of abdominal surgeries. Hence, rise in the usage of adhesion barrier products is projected to drive the 4DryField PH segment in the adhesion barriers market during the forecast period.
Request Broucher of the Report:
This post was originally published on The Market Plan